https://neurosciencenews.com/anti-amyloid-alzheimers-medication-22754/
0
0
Investigational Anti-amyloid Treatment Started Before Alzheimer’s Symptoms Did Not Slow Memory Loss - Neuroscience News
3/9/23 at 11:15pm
Organization
Neurosciencenews.com
Author
Neuroscience News
34 words
0
Comments
Solanezumab, an investigational anti-amyloid treatment, does not significantly slow the cognitive decline associated with Alzheimer's disease.
1 similar article
Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression - CNBC
You are the first to view
Create an account or login to join the discussion